Correlation Between Agios Pharm and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Ultragenyx, you can compare the effects of market volatilities on Agios Pharm and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Ultragenyx.
Diversification Opportunities for Agios Pharm and Ultragenyx
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Agios and Ultragenyx is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Agios Pharm i.e., Agios Pharm and Ultragenyx go up and down completely randomly.
Pair Corralation between Agios Pharm and Ultragenyx
Given the investment horizon of 90 days Agios Pharm is expected to generate 1.02 times more return on investment than Ultragenyx. However, Agios Pharm is 1.02 times more volatile than Ultragenyx. It trades about 0.06 of its potential returns per unit of risk. Ultragenyx is currently generating about 0.02 per unit of risk. If you would invest 3,032 in Agios Pharm on August 27, 2024 and sell it today you would earn a total of 2,536 from holding Agios Pharm or generate 83.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Ultragenyx
Performance |
| Timeline |
| Agios Pharm |
| Ultragenyx |
Agios Pharm and Ultragenyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Ultragenyx
The main advantage of trading using opposite Agios Pharm and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |